ArticleFrontiers in neurology2022

Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.

Ryan Kammeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.